SCHEDULE 13G/A: BlackRock Amends Passive Stake in Pliant Therapeutics, Reports 3.4% Ownership
Schedule 13G Amendment
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 3.4% beneficial ownership stake in Pliant Therapeutics Inc. common stock.
Summary
- BlackRock, Inc. reported beneficial ownership of 2,104,574 shares of Pliant Therapeutics Inc. common stock.
- This represents 3.4% of the class of securities.
- BlackRock holds sole voting power over 2,086,513 shares.
- BlackRock holds sole dispositive power over 2,104,574 shares.
- The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Pliant Therapeutics Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing passive ownership, providing no basis for positive or negative sentiment regarding the issuer's performance or outlook.
Management Comments
- BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake in the company.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of execution for the Power of Attorney granted by BlackRock, Inc. |
| 06/30/2025 | Date of event which required the filing of this statement. |
| 07/17/2025 | Date the Schedule 13G Amendment No. 1 was signed by BlackRock, Inc. |
Keywords
Pliant Therapeutics Inc., BlackRock Inc., Schedule 13G, Common Stock, Beneficial Ownership, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.